fig4
From: Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
![Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma](https://image.oaes.cc/95d97a06-9c1e-4152-83bf-65cd13a83297/3694.fig.4.jpg)
Figure 4. Kaplan-Meier curves for time to progression grouped according to pre-treatment NLR and pre-treatment PLR cutoff values. Censored events are represented by vertical lines. NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio